|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.91 USD | -2.82% |
|
-3.09% | -9.38% |
| 12:55am | Nordic stocks in North America, Astra Zeneca fell 1.4% | FW |
| 12:39am | Goldman Sachs raises Genmab price target to 2,350 Danish kroner (2,300), reiterates buy - BN | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENMAB A/S | Bio Therapeutic Drugs | -2.82% | -3.09% | -9.38% | +27.56% | -36.25% | 17.31B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Charts Genmab A/S
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
